DS
Publications
10
Views
2,657
Downloads
2,648
Supervised works
0
Items per page
1 - 10 of 10
Title Published in Access level OA Policy Year Views Downloads
Efficacy and Safety of Dolutegravir Plus Emtricitabine vs Combined Antiretroviral Therapy for the Maintenance of HIV Suppression : Results Through Week 144 of the SIMPL'HIV TrialOpen forum infectious diseases
accessLevelPublic
2024 6 38
Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy : the SIMPL'HIV open-label, factorial randomised controlled trialSwiss medical weekly
accessLevelPublic
2024 12 31
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trialBritish journal of clinical pharmacology
accessLevelRestricted
2021 221 0
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trialPLoS medicine
accessLevelPublic
2020 228 204
Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysisF1000Research
accessLevelPublic
2018 157 168
Stable HIV-1 reservoirs on dolutegravir maintenance monotherapy: the MONODO studyHIV Medicine
accessLevelPublic
2018 335 120
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort studyBMC Infectious Diseases
accessLevelPublic
2017 423 178
Is monotherapy maintenance the way forward ?The lancet. HIV
accessLevelPublic
2015 68 73
Haemophagocytic syndrome and elevated EBV load as initial manifestation of Hodgkin lymphoma in a HIV patient: case report and review of the literatureJournal of the International AIDS Society
accessLevelPublic
2014 585 454
Lipohypertrophy and metabolic disorders in HIV patients on antiretroviral therapy: a systematic multidisciplinary clinical approachJournal of the International AIDS Society
accessLevelPublic
2014 622 1,382
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack